- Key insight: Women need access to specialized care when using medication like GLP-1s or hormone replacements therapy.
- What’s at stake: Businesses risk seeing negative health outcomes among their midlife workforce if clinical gaps persist.
- Supporting data: Nearly 37% of women using these therapies reported a negative or nonexistent post-treatment experience.
Source: Bullets generated by AI with editorial review
Women are using GLP-1 and hormone therapy prescriptions to better manage their health, but when it comes to corresponding clinical support, their needs are going unfilled.
